Tag: PSA

Can you imagine having a PSA higher than 100–four prostate biopsies don’t find cancer? This is the true story of a 73-year old man who came to Duke University Medical Center early in 2021. When he was examined, his prostate gland was... keep reading

PSMA-PET scans have become the most sensitive prostate cancer (PCa) detection for metastasis (cancer that has spread to other parts of the body), including recurrent PCa after treatment. PET uses a radioactive tracer that has been molecularly bonded with a substance readily taken up by prostate specific membrane antigen (PSMA). keep reading

Contrary to popular belief, a new study says you’re never too old to get high-risk prostate cancer (PCa). There’s been a recent trend to cut back on PSA screening for men over age 70. It wasn’t that long ago when such organizations as the American Urological Society and the American Society of Clinical Oncology promoted keep reading

There’s an exciting new development in treating metastatic prostate cancer (PCa) that no longer responds to hormone therapy. Such cancer is clinically called metastatic castration-resistant prostate cancer, or mCRPC. There is currently no cure when PCa reaches this stage, but new drugs and immunotherapies can prolong life. Researchers are exploring and testing therapies that destroy keep reading

When it comes to men’s health, you’re a responsible guy, right? You don’t overdo it on dietary fats, sugars, red meat and alcohol; you work out regularly; and you have an annual physical. And, your annual exam includes a PSA blood test if you’re over age 45 (age 40 if you have known risk factors). keep reading

A 2021 paper describes the psychological anxiety and depression many patients feel when they are waiting for their biopsy results. Most men are already stressed just at the mere prospect of a needle biopsy. But then comes the period of not knowing while dread builds. Based on a validated questionnaire administered after a biopsy but before results were known... keep reading

Near the end of 2015, CMS (Centers for Medicare and Medicaid Services) proposed a mea­sure that would penalize doctors who ordered PSA tests. It would be an economic penalty, in some form of a fine. Aside from being a harsh measure, it would reinforce a trend already noted in published studies: since the US Preventive ...

keep reading

In September, 2018 we posted a blog on this promising news of the IsoPSA blood test for prostate cancer (PCa). Then, in October 2019, the FDA granted breakthrough device designation to the test, in order to work closely with the manufacturer to expedite approval. This move sprang from... keep reading

When it comes to spending money, you have choices. According to wealthfit.com, “Whether you spend 10 seconds or 10 days weighing a decision, each one comes with strings attached. With each option you choose, you’re saying ‘no’ to a different option. The value of what you do not select is called your opportunity cost. You keep reading

I have written in the past about the problems with using prostate specific antigen (PSA) as a screening tool for prostate cancer. Virtually all men over age 40 know they should have a PSA blood test at their annual exam, yet few have a complete understanding of what it really says... keep reading